Inscripta

OverviewSuggest Edit

Inscripta is a gene editing technology company dedicated to developing a family of CRISPR enzymes, MADzymes, bespoke nucleases for researchers and commercial partners. The Company also creates a full suite of gene editing tools, including software, instruments, and reagents that increase the speed and efficiency of precision gene editing.
TypePrivate
Founded2015
HQBoulder, US
Websiteinscripta.com

Latest Updates

Employees (est.) (Aug 2020)127(+2%)
Cybersecurity ratingAMore

Key People/Management at Inscripta

Kevin Ness

Kevin Ness

Chief Executive Officer
Jason T. Gammack

Jason T. Gammack

Chief Commercial Officer
Don Masquelier

Don Masquelier

VP Engineering
Michael Graige

Michael Graige

Chief Technical Officer
Dianna Devore

Dianna Devore

General Counsel
Todd Rubano

Todd Rubano

VP, Informations Systems & Software
Show more

Inscripta Office Locations

Inscripta has offices in Boulder, Pleasanton, Poway and San Diego
Boulder, US (HQ)
5500 Central Ave #220
Pleasanton, US
7026 Koll Center Pkwy #225
Poway, US
12740 Danielson Ct suite f
San Diego, US
5764 Pacific Center Blvd
Show all (4)

Inscripta Financials and Metrics

Summary Metrics

Founding Date

2015

Inscripta total Funding

$259.5 m

Inscripta latest funding size

$125 m

Time since last funding

8 months ago

Inscripta investors

Inscripta's latest funding round in December 2019 was reported to be $125 m. In total, Inscripta has raised $259.5 m
Show all financial metrics

Inscripta Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Inscripta Online and Social Media Presence

Embed Graph

Inscripta News and Updates

$125 million for Inscripta may usher in the next wave of genetic engineering

In these waning days of the second decade of the twenty-first century, technologists and investors are beginning to lay the foundations for new, truly transformational technologies that have the potential to reshape entire industries and rewrite the rules of human understanding. It may sound lofty, …

Inscripta Hires Chief Commercial Officer Jason T. Gammack to Bring Gene-Editing Tools to Market

BOULDER, Colo., Nov. 1, 2018 /PRNewswire/ -- Inscripta™, a leading gene-editing technology company, today announced the addition of Jason T. Gammack as the company's first chief commercial officer. Gammack, a 25-year veteran of life sciences commercial operations, will leverage his...

Meet the Startup That's Giving Away Its CRISPR-Like Technology For Free

CRISPRis one of the most promising areas in biotech, but much of that potential has been locked behind expensive licensing schemes.

Inscripta Blogs

Inscripta’s MAD7 Named a Top Innovation of 2018 by The Scientist

The award recognizes products that are set to revolutionize research and advance scientific knowledge. The post Inscripta’s MAD7 Named a Top Innovation of 2018 by The Scientist appeared first on Inscripta.

Inscripta Wins Rising Star Award from Colorado BioScience Association

Inscripta has been selected for the Colorado BioScience Association’s 2018 Rising Star Award The post Inscripta Wins Rising Star Award from Colorado BioScience Association appeared first on Inscripta.

Inscripta Announces Strategic Acquisition of Solana Biosciences

Boulder, Colo. – September 5, 2018 – Inscripta™, a leading gene-editing technology company, today announced the strategic acquisition of Solana Biosciences, a life sciences company founded by Illumina™ veterans. The post Inscripta Announces Strategic Acquisition of Solana Biosciences appeared first …

Inscripta Granted Patents for CRISPR Gene-Editing Systems

Boulder, Colo. – July 12, 2018 – Inscripta, a leading gene-editing technology company, today announced two significant milestones. First, the USPTO granted Inscripta its first patent covering systems using MAD7, the company’s first free CRISPR enzyme, as well as patent coverage for systems using ano…
Show more

Inscripta Frequently Asked Questions

  • When was Inscripta founded?

    Inscripta was founded in 2015.

  • Who are Inscripta key executives?

    Inscripta's key executives are Kevin Ness, Jason T. Gammack and Don Masquelier.

  • How many employees does Inscripta have?

    Inscripta has 127 employees.

  • Who are Inscripta competitors?

    Competitors of Inscripta include Osiris Therapeutics, Cryo-Cell and Repair Biotechnologies.

  • Where is Inscripta headquarters?

    Inscripta headquarters is located at 5500 Central Ave #220, Boulder.

  • Where are Inscripta offices?

    Inscripta has offices in Boulder, Pleasanton, Poway and San Diego.

  • How many offices does Inscripta have?

    Inscripta has 4 offices.